BOSTON, Massachusetts, October 25 /PRNewswire/ -- Cellzome Inc. announced today that its research collaboration with Novartis has been extended until 30 June 2008. Cellzome will continue to apply its proprietary technology to identify tractable therapeutic targets in several disease-relevant pathways, and to the identification of pharmacological targets, and potential off-target effects, of active Novartis compounds. Novel drug discovery projects have resulted from this work.
